A5073648948- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Long-Term Effects of COVID-19
- Corporate Social Responsibility Reporting
- Pharmacological Receptor Mechanisms and Effects
- Environmental Sustainability in Business
- Sustainable Supply Chain Management
- Sustainable Finance and Green Bonds
- Mechanical Circulatory Support Devices
- Innovation, Sustainability, Human-Machine Systems
- Respiratory Support and Mechanisms
University of California, Merced
2020-2022
Purpose The authors discuss how artificial intelligence (AI) can facilitate and incentivize reform in corporate social responsibility (CSR), i.e. governance with regard to pledge for socially responsible investments (SRIs). Design/methodology/approach current essay examines the impacts of AI systems on dynamics between financial markets terms promoting sustainability. Based a qualitative review over 100 pieces literature, we offer an outlook into mentioned through lens complex systems. Legal...
Purpose The authors revisit the inquiry into primacy of shareholders vis- à -vis stakeholders that has been debated since 19th Century. consider B-business firms as closest groups have considerable similarities to stakeholders' firms. model impact being certified (B-business) in a worldwide environment. Design/methodology/approach Employing daily returns data B-corporations global setting during 2010–2021, quantify and compare firms' performance pre- post-certified periods, measure effect...
The rapid expansion of a novel human infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved into pandemic, affecting thousands people world wild. Some patients with 2019 (COVID-19) develop infection, which may progress to distress syndrome, multiple organ failure, and death. Increasing studies indicate that abnormal elevation cytokine levels in response SARS-CoV-2 contribute the pathological process leads mortality COVID-19. Thus, application...
Coronavirus disease -19 (COVID-19) pandemic, caused by SARS-CoV-2, has gradually spread worldwide, becoming a major public health event. This situation requires designing novel antiviral agent against the SARS-CoV-2; however, this is time-consuming and use of repurposed medicines may be promising. One such medicine favipiravir, primarily introduced as an anti-influenza in east world. The aim study was to evaluate efficacy safety favipiravir comparison with lopinavir-ritonavir SARS-CoV-2...
Background. Due to the lack of specific safe medications for treatment COVID-19, used other similar conditions are being tested alleviate condition COVID-19 patients, resulting in acceptable outcomes some cases. Umifenovir (Arbidol®) is treat influenza viruses by inhibiting fusion virus with host cell. According previous findings, umifenovir may inhibit SARS-CoV-2 infection interfering release from inside This study aimed determine effects umifenovir, a inhibitor, versus lopinavir/ritonavir...